Nicaise Ndembi

Institute of Human Virology, Nigeria

Nicaise Ndembi brings, as the Head of the Laboratory Research of IHVN, to IHVN, a wealth of knowledge in molecular virology, clinical trials, HIV therapy, HIV drug resistance, and bioinformatics. Dr. Ndembi has set up the Asokoro Laboratory Training Centre for genotyping (HLA typing, HIV drug resistance testing, HCV, HBV, and HPV genotyping). Dr. Ndembi , who was educated at University of Yaoundé I, Yaoundé, Cameroon, and Kanazawa University, Kanazawa, Japan, has a Ph.D. degree in molecular virology and M.Phil. and M.S. degrees in biochemistry and molecular biology. Prior to his resumption in IHVN, he was the Head of the Molecular Virology Laboratory, MRC/UVRI Research Unit on AIDS, Medical Research Council (UK), and Uganda Virus Research Institute. He has also worked in academic and managerial capacities in Japan and Cameroon. Dr. Ndembi has several national and international fellowships and grants to his credit. He has received a scholarship for Ph.D. studies from the Japanese Ministry of Education, a senior fellowship award from the European and Developing Clinical Trials Partnership (EDCTP), a vocational award from Rotary International. He is also a coinvestigator on several NIH, MRC, and CDC research grants. He is a Member of the PharmAccess technical advisory board for resistance evaluation in Africa and served as a Consultant for the World Health Organization (WHO) for the WHO HIV ResNet Laboratory Working Group. Dr. Ndembi has authored and coauthored over 70 peer-reviewed publications in high impact factor journals (Lancet, Journal of Virology, PlosMedicine, AIDS, JID, and Lancet of Infectious Diseases) and over 100 abstracts and proceedings. He is part of the senior research team that has isolated HIV-1 group O and HIV-1 group P (A. Vallari, V. Holzmayer, B. Harris, J. Yamaguchi, C. Ngansop, F. Makamche, D. Mbanya, L. Kaptué, N. Ndembi, L. Gürtler, S. Devare, C. A. Brennan; confirmation of putative HIV-1 group P in Cameroon, Journal of Virology 2011 Feb, 85(3):1403-7.) and a Member of the DART Virology clinical trial group in Africa.

Biography Updated on 7 February 2013

Scholarly Contributions [Data Provided by ]